IONS Jul 2023 30.000 put
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 03:52PM EDT. Market open.
Loading interactive chart...
- Zacks
Ionis (IONS) Posts New Upbeat Data From Amyloidosis Drug Study
Ionis (IONS) reports positive long-term phase III study data, supporting the benefits of eplontersen as a treatment for hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN).
- Zacks
Why Is Ionis Pharmaceuticals (IONS) Down 8.4% Since Last Earnings Report?
Ionis Pharmaceuticals (IONS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Zacks
Ionis (IONS) Q4 Earnings Top Estimates, Sales Lag, Stock Down
Ionis (IONS) Q4 loss is narrower than expected. However, sales miss estimates. Revenue guidance for 2023 looks soft. Stock down.
© 2023 Yahoo. All rights reserved.
